The contract research organization uses technology to make clinical trial recruiting, execution and management more efficient.
“[W]e are in a time when we must take a look at how to repair or build the foundation of ophthalmology research with a more efficient, innovative and collaborative approach than ever before,” Ms. Swank said in an Aug. 2 company release. “I’m very excited about the days ahead for Vial Ophthalmology CRO.”
Ms. Swank will be working with Vial’s multidisciplinary scientific advisory board, according to the news release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
